MikroScore
Science-backed ingredient evidence
Moderate Evidence Safety: Use with caution Study dose: 400 mg/day

EGCG (Grüntee-Extrakt)

Also known as: Epigallocatechingallat, Grüner Tee Extrakt, Green Tea Extract, Catechine, EGC

Summary Moderate Evidence

EGCG is green tea's most abundant catechin, studied for metabolism and cellular protection. High-dose supplements carry documented liver toxicity risks.

EU Health Claims: No approved claims

No EFSA health claims approved for EGCG. In 2018, EFSA published an assessment: green tea catechins in supplements at doses ≥800 mg/day are classified as potentially hepatotoxic. As a beverage (regular tea), they are rated as safe.

AI Summary

Quick verdict

EGCG is green tea's most abundant catechin, studied for metabolism and cellular protection. High-dose supplements carry documented liver toxicity risks.

What the evidence supports

Multiple RCTs demonstrate antioxidant, anti-inflammatory, and metabolic effects (blood pressure, insulin, fat mass). AMPK activation and autophagy induction are well-characterized mechanistically.

What is NOT supported

Long-term safety and rare adverse effects in humans remain insufficiently studied.

EU/EFSA status

Not approved. No EFSA health claims approved for EGCG. In 2018, EFSA published an assessment: green tea catechi…

Safety

Use with caution

This AI summary is generated from the structured data on this page.

What is EGCG?

Epigallocatechin gallate (EGCG) is the most abundant and biologically active catechin in green tea. It comprises 50–80% of total catechin content and is the primary reason green tea has been intensively researched for decades.

Two mechanisms are especially relevant for healthy aging:

  • AMPK activation: AMPK is a cellular energy sensor. When activated, it promotes fat oxidation, inhibits mTOR, and stimulates autophagy (cellular self-cleaning)
  • Autophagy induction: EGCG directly enhances the removal of damaged cellular components—a central hallmark-of-aging mechanism

What do the studies really show?

Proven effects

  • LDL reduction: Meta-analyses consistently show decreases of 0.15–0.20 mmol/L
  • Inflammatory markers: CRP and IL-6 decline in RCTs
  • Blood pressure: Small but consistent reductions in multiple RCTs
  • Fat mass: Modest reduction (stronger when combined with caffeine)

Epidemiologically strong, causally unclear

  • Japanese studies: High green tea consumption correlates with fewer cardiovascular events and certain cancers
  • The problem: Confounding—green tea drinkers typically have healthier overall lifestyles

Not proven in humans

  • Direct lifespan extension
  • Strong cancer prevention in controlled trials

The safety issue with high-dose supplements

Here is where caution is warranted: In 2018, EFSA classified green tea catechins in concentrated supplements (≥800 mg/day) as potentially hepatotoxic. Multiple documented cases worldwide describe severe liver injury from EGCG supplements.

This applies to concentrated extracts in capsules—not regular green tea drinking, which EFSA rates as safe.

If you buy green tea extract: maximum 400–500 mg EGCG/day, never on an empty stomach, and avoid entirely if you have liver disease.

Drinking green tea vs. supplements

Three to five cups of green tea daily deliver 200–400 mg EGCG without toxicity risk and with epidemiologically well-studied benefits. This is the better option for most people compared to high-dose capsules.

Is EGCG safe?

At up to 400 mg/day from supplements: use cautiously. On an empty stomach it can cause nausea. Possible interactions with anticoagulants. Do not combine with iron supplements—EGCG inhibits iron absorption.

The mechanistic picture

EGCG’s effects center on three pathways:

AMPK/mTOR axis: In cell cultures and animal models, EGCG activates AMPK and suppresses mTOR, both linked to longevity. Whether this translates to humans remains uncertain.

Antioxidant and anti-inflammatory: EGCG is a potent free-radical scavenger. In inflammatory models, it reduces TNF-α and IL-6. Whether systemic inflammation meaningfully decreases in humans is debated.

Mitochondrial function: Preliminary evidence suggests EGCG may enhance mitochondrial biogenesis and reduce reactive oxygen species production, though human data are sparse.

Who benefits? Who should avoid?

Potential benefit:

  • Cardiovascular risk factors (LDL, blood pressure, inflammation)
  • Metabolic support (weight management, insulin sensitivity)
  • Antioxidant supplementation for those not drinking green tea regularly

Avoid entirely:

  • Liver disease or elevated liver enzymes
  • Taking anticoagulants (warfarin, DOACs)
  • Iron deficiency being treated—EGCG impairs absorption

Be cautious:

  • GI sensitivity (take with food)
  • Caffeine sensitivity (some extracts contain residual caffeine)
  • Pregnancy/breastfeeding (safety at high doses not established)

Dosing guidelines

  • From tea: 3–5 cups daily (200–400 mg EGCG)—preferred if feasible
  • From supplements: 300–400 mg/day maximum, with food, for 3–6 months at a time (rotate off periodically)
  • Never: >800 mg/day from concentrated supplements
  • Timing: With meals; avoid empty stomach

The bottom line

EGCG is among the most studied plant compounds, with real but modest effects on cardiovascular and metabolic markers in RCTs. The epidemiological case is stronger but confounded by lifestyle factors. Mechanistic evidence (AMPK, autophagy) is encouraging but not yet translatable to human longevity claims. The safety profile at high doses is concerning enough to justify the EU’s cautious stance.

For most people, drinking green tea is lower-risk and evidence-supported. If supplementing, stay ≤400 mg/day, always take with food, and monitor liver enzymes if using long-term. Those with liver disease or on anticoagulants should avoid entirely.

Key Studies

The Intrinsic Virtues of EGCG, an Extremely Good Cell Guardian, on Prevention and Treatment of Diabesity Complications

Potenza et al. (2020)

Comprehensive review: green tea catechins show inverse correlation with cardiovascular disease, metabolic dysfunction, and certain cancers in epidemiological studies. Causality remains unclear.

PubMed PMID 32635492

The metabolic effects of epigallocatechin-3-gallate: mechanisms and applications

Thielecke F & Boschmann M (2009)

Review: EGCG inhibits COMT, activates AMPK, and stimulates fat oxidation. Energy expenditure increases modestly (~80 kcal/day at 300 mg EGCG+caffeine).

PubMed PMID 19007524

Green tea catechins reduce total and LDL cholesterol: a systematic review and meta-analysis

Zheng XX et al. (2011)

Meta-analysis (14 RCTs): green tea catechins were significantly associated with lower LDL cholesterol (~0.19 mmol/L reduction) and total cholesterol.

PubMed PMID 21715508

Green tea extract induces genes related to browning of white adipose tissue and limits weight-gain in high fat diet-fed rat

Henning SM et al. (2018)

EGCG activates UCP1 (thermogenic protein) and promotes browning of white adipose tissue. Mechanistic basis for metabolic effects.

PubMed PMID 29684494
Editorial notice: For most ingredients described here, no health claims are approved in the EU (Regulation (EC) 1924/2006). Evidence levels are editorial assessments of research quality — not health promises. This content is not a substitute for medical advice and does not constitute a recommendation to treat, alleviate, or prevent any disease.